ELOXX PHARMACEUTICALS, INC. (ELOX) Capital expenditures 2012–2022
ELOXX PHARMACEUTICALS, INC. (ELOX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$66,000FY2022 · since FY2012: $4,461 → $66,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | $66,000 | -25.8% |
| FY2021 | $89,000 | — |
| FY2019 | $40,000 | -83.0% |
| FY2018 | $235,000 | -0.8% |
| FY2017 | $237,000 | +558.3% |
| FY2016 | $36,000 | +260.0% |
| FY2015 | $10,000 | +213.1% |
| FY2014 | $3,194 | +149.3% |
| FY2013 | $1,281 | -71.3% |
| FY2012 | $4,461 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice